Use of Complex crotoxina secreted phospholipase A2 and for the preparation of pharmaceutical compositions for the treatment and cosmeceuticas local and / or systemic infections caused by germs that Express Membrane glycerophospholipids

摘要

Use of phospholipase, e.g. - sPLA2 as an active Agent in the manufacture of Pharmaceutical / Cosmetic compositions for the treatment of pathogens is mediated by microorganisms, which comprises glicerofosfolu00edpidos Envelope (or Membrane).Particularly, the use of the Venom of crotalus durissus durisssus sPLA2 as Microbicide component for the preparation of compositions for the treatment of Viral Infections, particularly the States of Acquired Immunodeficiency. A method for the treatment of these disease States using the compositions described above.